NASDAQ : RLYB
Rallybio Corporation — Financial statements
Healthcare · Biotechnology · United States
Last price 15.41 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 81.83M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Rallybio Corporation (RLYB) reported revenue of 434.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 434.00K | 858.00K | 636.00K | |||
| Cost of Revenue | 6.27M | 18.40M | 39.51M | 53.54M | ||
| Gross Profit | -5.83M | -17.54M | -38.87M | -53.54M | ||
| Selling, General & Admin | 16.09M | 13.82M | 18.32M | 25.39M | 27.20M | 18.74M |
| Research & Development | 40.69M | 26.91M | ||||
| Operating Expenses | 16.09M | 13.82M | 18.32M | 25.39M | 67.88M | 45.65M |
| Operating Income | -21.92M | -31.36M | -57.20M | -78.93M | -67.88M | -45.65M |
| Interest Expense | -10.00K | |||||
| Interest & Investment Income | 2.45M | 2.19M | 4.22M | 6.15M | 1.96M | 54.00K |
| Earnings From Equity Investments | -874.00K | -2.24M | -2.04M | -1.07M | -1.50M | |
| Other Non Operating Income (Expenses) | 421.00K | 744.00K | 262.00K | 342.00K | 96.00K | |
| EBT Excluding Unusual Items | -19.47M | -29.63M | -54.48M | -74.56M | -66.65M | -47.01M |
| Merger & Restructuring Charges | 47.70M | -1.70M | -3.30M | |||
| Gain (Loss) on Sale of Investments | 22.35M | |||||
| Pretax Income | 28.21M | -8.98M | -57.77M | -74.56M | -66.65M | -47.01M |
| Income Tax Expense | 1.40M | |||||
| Net Income | 26.81M | -8.98M | -57.77M | -74.56M | -66.65M | -47.01M |
| Net Income to Common | 26.81M | -8.98M | -57.77M | -74.56M | -66.65M | -47.01M |
| Shares Outstanding (Basic) | 5.70M | 5.63M | 5.44M | 5.06M | 3.98M | 3.19M |
| Shares Outstanding (Diluted) | 5.76M | 5.63M | 5.44M | 5.06M | 3.98M | 3.19M |
| EPS (Basic) | 4.71 | -1.59 | -10.61 | -14.75 | -16.76 | -14.74 |
| EPS (Diluted) | 4.65 | -1.59 | -10.61 | -14.75 | -16.76 | -14.74 |
| Free Cash Flow | 30.99M | -29.81M | -49.28M | -60.28M | -57.34M | -45.87M |
| Free Cash Flow Per Share | 5.38 | -5.30 | -9.05 | -11.92 | -14.41 | -14.38 |
| Operating Margin | -5,050.92% | -3,655.48% | -8,993.08% | |||
| Profit Margin | 6,177.42% | -1,046.39% | -9,084.12% | |||
| Free Cash Flow Margin | 7,139.63% | -3,474.71% | -7,748.74% | |||
| EBITDA | -21.91M | -31.27M | -57.06M | -78.78M | -67.72M | -45.54M |
| D&A For EBITDA | 8.00K | 92.00K | 131.00K | 150.00K | 167.00K | 109.00K |
| EBIT | -21.92M | -31.36M | -57.20M | -78.93M | -67.88M | -45.65M |
| Revenue as Reported | 434.00K | 858.00K | 636.00K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 90.69M | 31.37M | 13.90M | 24.49M | 56.96M | 175.33M |
| Short-Term Investments | 23.36M | 51.61M | 85.44M | 112.04M | ||
| Cash & Short-Term Investments | 90.69M | 54.74M | 65.51M | 109.93M | 168.99M | 175.33M |
| Prepaid Expenses | 1.35M | 628.00K | 638.00K | 739.00K | 1.55M | 1.84M |
| Other Current Assets | 2.72M | 5.89M | 1.69M | 4.12M | 8.95M | 3.70M |
| Total Current Assets | 94.77M | 61.25M | 67.84M | 114.79M | 179.50M | 180.87M |
| Property, Plant & Equipment | 198.00K | 267.00K | 592.00K | 909.00K | 511.00K | |
| Long-Term Investments | 239.00K | 30.00K | 805.00K | |||
| Other Long-Term Assets | 810.00K | 810.00K | ||||
| Total Assets | 95.58M | 62.26M | 68.11M | 115.62M | 180.44M | 182.19M |
| Accounts Payable | 7.00K | 126.00K | 278.00K | 976.00K | 1.11M | 603.00K |
| Accrued Expenses | 1.93M | 3.79M | 4.96M | 8.07M | 9.45M | 5.95M |
| Current Portion of Leases | 94.00K | 154.00K | 219.00K | 181.00K | ||
| Current Unearned Revenue | 212.00K | 848.00K | ||||
| Total Current Liabilities | 3.28M | 4.22M | 6.24M | 9.26M | 10.74M | 6.55M |
| Long-Term Leases | 82.00K | 173.00K | 374.00K | |||
| Long-Term Unearned Revenue | 212.00K | |||||
| Other Long-Term Liabilities | 32.00K | |||||
| Total Liabilities | 3.28M | 4.30M | 6.45M | 9.44M | 11.12M | 6.58M |
| Common Stock | 4.00K | 4.00K | 4.00K | 4.00K | 4.00K | 3.00K |
| Additional Paid-In Capital | 361.63M | 359.93M | 354.60M | 341.41M | 330.21M | 269.63M |
| Retained Earnings | -269.34M | -302.00M | -293.02M | -235.25M | -160.68M | -94.03M |
| Comprehensive Income & Other | 18.00K | 68.00K | 15.00K | -214.00K | ||
| Total Common Equity | 92.30M | 57.96M | 61.65M | 106.18M | 169.32M | 175.60M |
| Shareholders' Equity | 92.30M | 57.96M | 61.65M | 106.18M | 169.32M | 175.60M |
| Total Liabilities & Equity | 95.58M | 62.26M | 68.11M | 115.62M | 180.44M | 182.19M |
| Total Debt | 176.00K | 154.00K | 392.00K | 555.00K | ||
| Net Cash (Debt) | 90.69M | 54.56M | 65.36M | 109.54M | 168.44M | 175.33M |
| Net Cash Per Share | 15.74 | 9.69 | 12.01 | 21.67 | 42.35 | 54.97 |
| Filing Date Shares Outstanding | 5.38M | 5.29M | 5.20M | 4.73M | 4.76M | 4.02M |
| Total Common Shares Outstanding | 5.33M | 5.28M | 5.19M | 4.73M | 4.73M | 4.02M |
| Working Capital | 91.49M | 57.03M | 61.60M | 105.53M | 168.75M | 174.32M |
| Book Value Per Share | 17.31 | 10.97 | 11.88 | 22.46 | 35.80 | 43.72 |
| Tangible Book Value | 92.30M | 57.96M | 61.65M | 106.18M | 169.32M | 175.60M |
| Tangible Book Value Per Share | 17.31 | 10.97 | 11.88 | 22.46 | 35.80 | 43.72 |
| Machinery | 267.00K | 342.00K | 342.00K | 331.00K | 305.00K | |
| Construction In Progress | 8.00K | |||||
| Leasehold Improvements | 147.00K | 338.00K | 338.00K | 338.00K | 315.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 26.81M | -8.98M | -57.77M | -74.56M | -66.65M | -47.01M |
| Depreciation & Amortization | 8.00K | 92.00K | 131.00K | 150.00K | 167.00K | 109.00K |
| Loss (Gain) From Sale of Investments | -153.00K | -22.92M | -1.61M | -3.09M | -435.00K | |
| Loss (Gain) on Equity Investments | 874.00K | 2.24M | 2.04M | 1.07M | 1.50M | |
| Stock-Based Compensation | 2.22M | 5.31M | 7.99M | 10.92M | 9.50M | 3.65M |
| Change in Accounts Payable | -262.00K | -152.00K | -698.00K | -99.00K | 487.00K | -976.00K |
| Change in Unearned Revenue | -424.00K | -848.00K | 1.06M | |||
| Change in Other Net Operating Assets | 2.77M | -3.19M | -620.00K | 4.38M | -1.42M | -2.80M |
| Operating Cash Flow | 30.99M | -29.81M | -49.28M | -60.27M | -57.28M | -45.53M |
| Capital Expenditures | -12.00K | -54.00K | -333.00K | |||
| Investment in Securities | 27.32M | 47.27M | 33.49M | 27.67M | -112.12M | -2.00M |
| Investing Cash Flow | 27.32M | 47.27M | 33.49M | 27.66M | -112.17M | -2.33M |
| Issuance of Common Stock | 260.00K | 16.00K | 5.47M | 282.00K | 51.77M | 86.20M |
| Other Financing Activities | -268.00K | -139.00K | -693.00K | -3.23M | ||
| Financing Cash Flow | 260.00K | 16.00K | 5.20M | 143.00K | 51.08M | 82.97M |
| Net Cash Flow | 58.57M | 17.47M | -10.59M | -32.46M | -118.38M | 35.10M |
| Free Cash Flow | 30.99M | -29.81M | -49.28M | -60.28M | -57.34M | -45.87M |
| Free Cash Flow Margin | 7,139.63% | -3,474.71% | -7,748.74% | |||
| Free Cash Flow Per Share | 5.38 | -5.30 | -9.05 | -11.92 | -14.41 | -14.38 |
| Levered Free Cash Flow | -9.39M | -20.34M | -28.05M | -34.15M | -33.77M | -28.91M |
| Unlevered Free Cash Flow | -9.39M | -20.34M | -28.05M | -34.15M | -33.77M | -28.91M |
| Change in Working Capital | 2.09M | -4.19M | -258.00K | 4.28M | -936.00K | -3.78M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 83.67M | 28.98M | 39.83M | 90.33M | 248.60M | 306.52M |
| Enterprise Value | -7.03M | -30.14M | -35.08M | -30.63M | 116.77M | 119.54M |
| Last Close Price | 15.54 | 5.49 | 7.68 | 19.12 | 52.56 | 76.32 |
| PS Ratio | 192.78 | 33.78 | 62.62 | |||
| PB Ratio | 0.90 | 0.50 | 0.65 | 0.85 | 1.47 | 1.75 |
| P/TBV Ratio | 0.91 | 0.50 | 0.65 | 0.85 | 1.47 | 1.75 |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Net Debt / Equity Ratio | -0.98 | -0.94 | -1.06 | -1.03 | -0.99 | -1.00 |
| Net Debt / EBITDA Ratio | 4.14 | 1.75 | 1.15 | 1.39 | 2.49 | 3.85 |
| Net Debt / FCF Ratio | -2.93 | 1.83 | 1.33 | 1.82 | 2.94 | 3.82 |
| Asset Turnover | 0.01 | 0.01 | 0.01 | |||
| Quick Ratio | 27.62 | 12.96 | 10.49 | 11.87 | 15.73 | 26.76 |
| Current Ratio | 28.87 | 14.51 | 10.87 | 12.39 | 16.71 | 27.61 |
| Return on Equity (ROE) | 34.52% | -15.01% | -68.85% | -54.13% | -38.65% | -30.18% |
| Return on Assets (ROA) | -16.79% | -30.07% | -38.91% | -33.33% | -23.40% | -17.61% |
| Return on Capital Employed (ROCE) | -23.80% | -54.00% | -92.50% | -74.20% | -40.00% | -26.00% |
| Earnings Yield | 29.94% | -30.98% | -145.06% | -82.55% | -26.81% | -15.34% |
| FCF Yield | 37.04% | -102.86% | -123.74% | -66.73% | -23.06% | -14.96% |
| Buyback Yield / Dilution | -2.81% | -3.42% | -7.66% | -27.11% | -24.70% | -46.76% |